Is small for gestational age status associated with an increased risk of atherogenesis?

Ramona Stroescu1, Ioana Micle2, Otilia Marginean1

  • 1"Louis Turcanu" Emergency Hospital for Children Timisoara, Romania ; "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania.

Maedica
|May 3, 2014
PubMed

Insights

Children born small for gestational age (SGA) who become obese show increased carotid intima-media thickness (CIMT), a marker of atherosclerosis. Metabolic factors like high triglycerides and insulin resistance are key predictors of this risk.

Area of Science:

  • Pediatrics
  • Cardiology
  • Endocrinology

Background:

  • Children born small for gestational age (SGA) are at risk for early-onset obesity and metabolic syndrome (MetS).
  • Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis, indicating atherogenesis.
  • Understanding the link between SGA, obesity, and CIMT is crucial for early intervention.

Purpose of the Study:

  • To determine the association between being born SGA and CIMT in obese children.
  • To investigate the impact of metabolic risk factors on CIMT in this population.

Main Methods:

  • A prospective study analyzed 122 obese children (26 SGA, 96 appropriate for gestational age [AGA]), matched for age, sex, and BMI.
  • Measurements included blood pressure, lipids, glucose, oral glucose tolerance tests (oGTT), homeostasis model assessment (HOMA) for insulin resistance (IR), and CIMT.
  • Data were collected over a 1-year period.

Main Results:

  • Obese children born SGA exhibited significantly increased CIMT compared to obese AGA children (p=0.0035).
  • CIMT strongly correlated with metabolic factors (r=0.98).
  • Diastolic blood pressure, triglycerides, and HOMA were significantly related to CIMT in both groups.

Conclusions:

  • Metabolic syndrome components, including high triglycerides, low HDL-cholesterol, IR, and diastolic blood pressure, are strong predictors of increased CIMT in obese children.
  • Being born SGA independently increases the risk of atherogenesis in obese children.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K